Altaroc
Companies
Solve Therapeutics
Manager
Fund |
Manager |
Co-invested company
sector
Healthcare
regional split
North America
vintage
status
Portfolio
category
Positive impact
General Atlantic 2021
General Atlantic

Solve Therapeutics

Co-invested company
Solve Therapeutics is a leading pharmaceutical company focused on the research and development of innovative therapies for neurodegenerative and psychiatric diseases.
Design representing Solve Therapeutics, part of the Private Equity manager's portfolio General Atlantic

Key figures for Solve Therapeutics

25
people
2021
year of inception
126 M$
surveys
2
acquisitions since inception
Data as at
18/3/26
*Source: Public data from companies’ websites and social media accounts. For more up-to-date information, we invite our investors to view the report made available on their space.

The Altaroc Odyssey 2021 fpci is closed for business.

About Solve Therapeutics

Based in California, it employs some twenty researchers and recently acquired Cereius, a pioneer in antibody-based treatments.  

Its multi-disciplinary approach has enabled it to advance medicine by creating effective treatments for major psychiatric pathologies (Alzheimer's disease, autism spectrum disorders, etc.) that were previously difficult to treat with drugs.

Led by a team of former researchers from major pharmaceutical companies who bring their solid experience to the company, Solve Therapeutics invests heavily in research and establishes strategic partnerships with renowned academic institutions.

Having raised $126 million, the company has established itself as a major player in psychiatric research in North America just two years after its creation, and aims to consolidate its position through further acquisitions.

In the same sector as Solve Therapeutics

Company videos
No items found.

Discover the new Vintage Altaroc Odyssey 2025

Discover the Vintage Altaroc Horizon

General Atlantic
Odyssey 2021
Odyssey 2021
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Portfolio
Welcome to Altaroc
To provide you with a tailored experience, we invite you to complete your profile.
Your profile
country of tax residence
Select
choosenCountry
Preferred language
Select
choosenLang
Your investor profile
Financial intermediary or Professional investor
Financial advisors, wealth management advisors, private bankers, or any other investment service providers.
Qualified Investor or Altaroc Investor
Experienced Investor or Altaroc Investor
Private investors who have already invested in Altaroc who have a minimum investment capacity of €100,000.
Private investors who have already invested in Altaroc who have a minimum investment capacity of €250,000.
Inexperienced investor
Individual investors with an investment capacity of less than €100,000.
Individual investors with an investment capacity of less than €250,000.
Institutional investor
Pension funds, retirement funds, asset management firms, and single-family offices.
Scroll down to accept General Terms and Conditions
The webpage you are trying to access is not available in your country.